Thomas H. Mclain

Filings by Thomas H. Mclain span 2 companies, the busiest being Eastman Chemical Co and Vaxart, Inc. Between 24 February 2006 and 30 November 2011, the trades on record add up to 20 filings.

In open-market terms, that means 1 purchase worth €48k on one side and 5 sales worth €589k on the other. The net balance comes to €540k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 8 share grants and 5 option exercises. 2011 to date brings no purchases and 5 sales.

The newest entry dates from 2 December 2011: an open-market sale of €118k, in Eastman Chemical Co. The last purchase on record was published on 29 May 2007, which is 7,104 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.